- PROFESSOR Medicine, Infectious Diseases
- PROFESSOR Pathology
B.S., University of Michigan
M.D., Wayne State University
Residency, Montefiore Medical Center
Fellowship, Memorial Sloan-Kettering Cancer Center
- Bruce Polsky, MD, MACP, FIDSA is the Chairman of the Department of Medicine, Medical Director of the Clinical Virology Laboratory and Hospital Epidemiologist at Mount Sinai St. Luke's and Mount Sinai Roosevelt Hospitals and Professor of Medicine and Pathology at the
Icahn School of Medicine at Mount Sinai in New York City. A graduate of the University of Michigan and Wayne State University School of Medicine, Dr. Polsky is a Master of the American College of Physicians, a Fellow of the Infectious Diseases Society of America and the New York Academy of Medicine. Prior to, and for several years after, his appointment as Chairman, he also served as Chief, Division of Infectious Diseases at St. Luke's and Roosevelt Hospitals (1998-2012) and was the John H. Keating Sr. Professor of Medicine at Columbia University Medical Center and the College of Physicians and Surgeons (2009-2013).
He has been active in clinical investigations into HIV/AIDS, HBV, HCV and other viral infections, as well as anti-infective therapy drug development -- including antivirals, antifungals and antibacterial agents, as well as clinical diagnostic platforms for infectious diseases -- since the early 1980s when he was at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College (1983-1998). He is currently the Co-Chair of the Study Monitoring Committee of the Hepatitis Transformational Science Group of the Adult AIDS Clinical Trials Group funded by NIH-NIAID and is the immediate past chair of the Publications Committee of the Infectious Diseases Society of America. Dr. Polsky has published extensively on antiviral drug development and on infectious complications in the immunocompromised host -- particularly cancer and AIDS.
American College of Physicians
Infectious Diseases Society of America
New York Academy of Medicine
2005 - 2013
America’s Top Doctors for Cancer
2002 - 2014
America’s Top Doctors
2002 - 2014
Top Doctors: New York Metro Area
ResearchDr. Polsky’s research has been focused on clinical investigations into HIV/AIDS, HBV, HCV and other viral infections, as well as anti-infective therapy drug development -- including antivirals, antifungals and antibacterial agents, as well as clinical diagnostic platforms for infectious diseases.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Polsky during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- CorMedix Inc.
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Vision-Sciences, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.